Komrower lecture: Treatment of inborn errors of metabolism: A review

Journal of Inherited Metabolic Disease

Volumn 29, Issue 2-3, 2006, Pages 275-278

  Leonard, J V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININOSUCCINIC ACID; ARYLBUTYRIC ACID DERIVATIVE; BENZOIC ACID; GALACTOSE; HYDROXOCOBALAMIN; PLACEBO;

CITRULLINEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DATA COLLECTION METHOD; DIET RESTRICTION; DIET THERAPY; DISEASE COURSE; DRUG MEGADOSE; EARLY DIAGNOSIS; ENZYME REPLACEMENT; FABRY DISEASE; FOLLOW UP; GALACTOSEMIA; GENETIC ANALYSIS; HUMAN; HYPERGLYCINEMIA; INBORN ERROR OF METABOLISM; LONG TERM CARE; MEDICAL DECISION MAKING; MELAS SYNDROME; METHYLMALONIC ACIDEMIA; NEWBORN PERIOD; NEWBORN SCREENING; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; REVIEW; STANDARDIZATION; STATISTICAL MODEL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; METABOLISM, INBORN ERRORS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 33745062896     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0273-4     Document Type: Review

References (24)

1. Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, Segal S (1995) Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet 346: 1073-1074.
2. Brusilow-SW (2001) Urea cycle enzymes. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1909-1963.
3. Cederbaum SD, Koo-McCoy S, Tein I, et al (2002) Carnitine membrane transporter deficiency: A long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol Genet Metab 77: 195-201.
4. Christensen E, Ribes A, Busquets C, et al (1997) Compound heterozygosity in the glutaryl-CoA dehydrogenase gene with R227P mutation in one allele is associated with no or very low free glutarate excretion. J Inherit Metab Dis 20: 383-386.
5. Eng CM, Guffon N, Wilcox WR, et al (2001) International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med 345: 9-16.
6. Fishler K, Donnell GN, Bergren WR, Koch R (1972) Intellectual and personality development in children with galactosemia. Pediatrics 50: 412-419.
7. Gitzelman R, Hansen RG (1980) Galactose metabolism, hereditary defects and their clinical significance. In: Burman D, Holton JB, Pennock CA, eds. Inherited Disorders of Carbohydrate Metabolism. Lancaster: MTP Press, 61-101.
8. Greenberg CR, Prasad AN, Dilling LA, et al (2002) Outcome of the first 3 years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75: 70-78.
9. Hamosh A, Johnston MV (2001) Non-ketotic hyperglycinaemia. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2065-2078.
10. Holton JB, Walter JH, Tyfield LA (2001) Galactosaemia. In: Scriver CR, Beaudet al, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1553-1587.
11. Jaeken J, Kint J, Spaapen L (1992) Serum lysosomal abnormalities in galactosaemia. Lancet 340: 1472.
12. Kölker S, Garbade SF, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in glutaryl-CoA dehydrogenase deficiency, submitted for publication.
13. Komrower GM, Lee DH (1970) Long-term follow-up of galactosaemia. Arch Dis Child 45: 367-373.
14. Lamhonwah AM, Olpin SE, Pollitt RJ, et al (2002) Novel OCTN2 mutations: no genotype-phenotype correlations: Early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111: 271-284.
15. Lee PJ, Lilburn M, Wendel U, Schadewaldt P (2003) A woman with untreated galactosaemia. Lancet 362: 446.
16. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340: 813-817.
17. Saudubray JM, Touati G, Delonlay P, et al (1999) Liver transplantation in urea cycle disorders. Eur J Pediatr 158 (Supplement 2): S55-S59.
18. Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U (2004) Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol Genet Metab 81: 31-44.
19. Touati G, Valayannopoulos V, Mention K, et al (2006) Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis 29: 288-298.
20. Waggoner DD, Buist NR, Donnell GN (1990) Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J Inherit Metab Dis 13: 802-818.
21. von Wendt L, Simila S, Saukkonen AL, Koivisto M (1980) Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia. Pediatrics 65: 1166-1169.
22. Widhalm K, Koch S, Scheibenreiter S, et al (1992) Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: No impairment of intellectual and psychomotor development during therapy. Pediatrics 89: 1182-1184.
23. Wolf B (2001) Disorders of biotin metabolism. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3935-3964.
24. Yannicelli S (2006) Nutrition therapy of organic acidaemias with amino acid-based formulas: Emphasis on methylmalonic and propionic acidaemia. J Inherit Metab Dis 29: 281-287.